Human renal cancer stem cells

Cancer Letters

Volumn 338, Issue 1, 2013, Pages 141-146

  Bussolati, Benedetta ^a   Dekel, Benjamin ^b   Azzarone, Bruno ^c   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b TEL AVIV UNIVERSITY   (Israel)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Angiogenesis; Differentiation therapy; Renal cell carcinoma; Tumor stem cells; Wilms' tumor

Indexed keywords

CD133 ANTIGEN; ENDOGLIN; INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 15; TRANSCRIPTION FACTOR PAX2; UVOMORULIN; WT1 PROTEIN;

CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STEM CELL; CELL ASSAY; CELL DIFFERENTIATION; CELL INTERACTION; CELL ISOLATION; CELL LINEAGE; CELL SELECTION; CELL SUBPOPULATION; CHILDHOOD CANCER; CYTOFLUOROMETRY; DISEASE ASSOCIATION; DRUG TARGETING; EMBRYONIC STEM CELL; EPIGENETICS; EXOSOME; GENE; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; NEPHROBLASTOMA; NONHUMAN; PAX2 GENE; PREMETASTATIC NICHE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SHORT SURVEY; SIX2 GENE; STEM CELL NICHE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; WNT SIGNALING PATHWAY; WT1 GENE;

EID: 84882889737     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.05.007     Document Type: Review

References (60)

1. Koul H., Huh J.S., Rove K.O., et al. Molecular aspects of renal cell carcinoma: a review. Am. J. Cancer Res. 2011, 1:240-254.
2. Kovacs G., Akhtar M., Beckwith B.J., et al. The Heidelberg classification of renal cell tumors. J. Pathol. 1997, 183:131-136.
3. Coppes M.J., Pritchard-Jones K. Principles of Wilms' tumor biology. Urol. Clin. North. Am. 2000, 27:423-433.
4. Coppin C., Kollmannsberger C., Le L., et al. Targeted therapy for advanced renal cell cancer (RCC): a cochrane systematic review of published randomised trials. BJU Int. 2011, 108:1556-1563.
5. Reya T., Morrison S.J., Clarke M.F., et al. Stem cells, cancer, and cancer stem cells. Nature 2011, 414:105-111.
6. Friedman G.K., Yancey Gillespie G. Cancer stem cells and pediatric solid tumors. Cancers 2011, 3:298-318.
7. Sell S. On the stem cell origin of cancer. Am. J. Pathol. 2010, 176:2584-2594.
8. Bussolati B., Bruno S., Grange C., et al. Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J. 2008, 22:3696-3705.
9. Bussolati B., Bruno S., Grange C., et al. Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol. 2005, 166:545-555.
10. Sallustio F., De Benedictis L., Castellano G., et al. TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J. 2010, 24:514-525.
11. + progenitors through Oct4/miR-145 balance. Am. J. Physiol. Renal Physiol. 2012, 302:F116-F128.
12. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
13. O'Brien C.A., Pollett A., Gallinger S., et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
14. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
15. Li C., Heidt D.G., Dalerba P., et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
16. Collins A.T., Berry P.A., Hyde C., et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
17. + cells display stem-like features and are spared by cisplatin treatment. PNAS 2009, 106:16281-16286.
18. + renal progenitor cells contribute to tumor angiogenesis. Am. J. Pathol. 2006, 169:2223-2235.
19. Addla S., Brown M., Hart C., et al. Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells. Am. J. Physiol. Renal Physiol. 2008, 295:F680-F687.
20. D'Alterio C., Cindolo L., Polimeno M., et al. Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle 2010, 9:4492-4500.
21. da Costa W.H., Rocha R.M., da Cunha I.W., et al. CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma. World J. Urol. 2011, (October 4). (Epub ahead of print).
22. Zhong Y., Guan K., Guo S., et al. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett. 2010, 299:150-160.
23. Goodell M.A., Brose K., Paradis G., et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996, 183:1797-1806.
24. Hughes C., Liew M., Sachdeva A., et al. SR-FTIR spectroscopy of renal epithelial carcinoma side population cells displaying stem cell-like characteristics. Analyst 2010, 135:3133-3141.
25. Rivera M.N., Haber D.A. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat. Rev. Cancer 2005, 5:699-7121.
26. Velasco S., D'Amico D., Schneider N.R., et al. Molecular and cellular heterogeneity of Wilms' tumor. Int. J. Cancer 1993, 53:672-679.
27. Dekel B., Metsuyanim S., Schmidt-Ott K.M., et al. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Res. 2006, 66:6040-6049.
28. Metsuyanim S., Pode-Shakked N., Schmidt-Ott K.M., et al. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. Stem cells 2008, 26:1808-1817.
29. Aiden A.P., Rivera M.N., Rheinbay E., et al. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network. Cell Stem Cell 2010, 6:591-602.
30. Hu Q., Gao F., Tian W., et al. Wt1 Ablation and Igf2-Up-regulation in mice result in Wilms tumors with activated pERK1/2. J. Clin. Invest. 2011, 121:174-183.
31. Polyak K., Hahn W.C. Roots and stems: stem cells in cancer. Nat. Med. 2006, 12:296-300.
32. Liitle M. Wilms' tumor: starting off the kidney all over again?. Prog. Mol. Subcell. Biol. 2005, 40:107-132.
33. Pode-Shakked N., Dekel B., et al. Wilms' tumor - a renal stem cell malignancy?. Pediatr. Nephrol. 2011, 26:1535-1543.
34. Pode-Shakked N., Metsuyanim S., Rom-Gross E., et al. Developmental tumorigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population. J. Cell Mol. Med. 2009, 13:1792-1808.
35. Pode-Shakked N., Harari-Steinberg O., Haberman-Ziv Y., et al. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target. Oncogene 2011, 30:1664-1680.
36. Kim W.Y., Kaelin W.G. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 2004, 22:4991-5004.
37. Kaelin W.G. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer 2002, 2:673-682.
38. Ratajczak J., Wysoczynski M., Hayek F., et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
39. Camussi G., Deregibus M.C., Bruno S., et al. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am. J. Cancer Res. 2011, 1:98-110.
40. Grange C., Tapparo M., Collino F., et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011, 71:5346-5356.
41. Dong J., Zhao Y., Huang Q., et al. Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation. Stem Cell Rev. 2011, 7:141-152.
42. Ricci-Vitiani L., Pallini R., Biffoni M., et al. Tumor vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
43. Wang R., Chadalavada K., Wilshire J., et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468:829-833.
44. Zhao Y., Dong J., Huang Q., et al. Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro. Brain Res. Bull. 2010, 82:308-312.
45. Xiong Y.Q., Sun H.C., Zhang W., et al. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin. Cancer Res. 2009, 15:4838-4846.
46. Alvero A.B., Fu H.H., Holmberg J., et al. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 2009, 27:2405-2413.
47. Bussolati B., Grange C., Sapino A., et al. Endothelial cell differentiation of human breast tumour stem/progenitor cells. J. Cell Mol. Med. 2009, 13:309-319.
48. Bussolati B., Grange C., Camussi G., et al. Tumor exploits alternative strategies to achieve vascularization. FASEB J. 2011, 25:2874-2882.
49. Heldevein F., Escudier B., Smyth G., et al. Metastatic renal cell carcinoma management. Int. Braz. J. Urol. 2009, 35:256-270.
50. Sehl M.E., Sinsheimer J.S., Zhou H., et al. Differential destruction of stem cells: implications for targeted cancer stem cell therapy. Cancer Res. 2009, 69:9481-9489.
51. Smith K.M., Datti A., Fujitani M., et al. Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens. EMBO Mol. Med. 2010, 2:371-384.
52. Azzi S., Bruno S., Giron-Michel J., et al. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. J. Natl. Cancer Inst. 2011, 103:1884-1898.
53. Shinozaki M., Hirahashi J., Lebedeva T., et al. IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J. Clin. Invest. 2002, 109:951-960.
54. Eini H., Tejman-Yarden N., Lewis E.C., et al. Association between renal injury and reduced interleukin-15 and interleukin-15 receptor levels in acute kidney injury. J. Interferon Cytokine Res. 2010, 30:1-8.
55. Giron-Michel J., Azzi S., Khawam K., et al. Interleukin-15 plays a central role in human kidney physiology and cancer through the c signaling pathway. PLoS One. 2012, 7:e31624.
56. Trinder P., Seitzer U., Gerdes J., et al. Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. Int. J. Oncol. 1999, 14:23-31.
57. Le Floc'h A., Jalil A., Vergnon I., et al. Alpha E beta 7 integrin interaction with Ecadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J. Exp. Med. 2007, 204:559-570.
58. + intraepithelial T cells. Transplantation 2003, 75:505-514.
59. Senju S., Matsunaga Y., Fukushima S., et al. Immunotherapy with pluripotent stem cell-derived dendritic cells. Semin. Immunopathol. 2011, 33:603-612.
60. Soleimani A., Berntsen A., Svane I.M., et al. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate. Scand. J. Immunol. 2009, 70:481-489.